Personalized Biomedicine in Cancer: From Traditional Therapy To Sustainable Healthcare

dc.contributor.author Ulu,G.T.
dc.contributor.author Kiraz,Y.
dc.contributor.author Baran,Y.
dc.date.accessioned 2024-09-24T15:54:17Z
dc.date.available 2024-09-24T15:54:17Z
dc.date.issued 2020
dc.description.abstract What images are coming to your mind when you think about sustainable and qualified life? The main picture drawn is healthcare. Many people suffer from cancer; more than 18.1 million people were diagnosed with cancer and 9.6 million people died from cancer worldwide in 2018. Therefore many diagnosis and treatment strategies that are shaped and regulated by biomedicine approaches have been developed to solve this problem. Biomedicine is an interdisciplinary science to understand the interaction of biological, chemical, and physiological principles. These principles should be brought together to be applicable and sustainable for qualified life. Drug discovery and combination therapy using nanocarriers and natural compounds are being innovated as new approaches and opportunities for cancer treatment. Theoretically and practically, there is no limit to the development of new biomedicinal tools for personalized medicine in cancer. Therefore personalized medicine plays an important role for reaching successful therapy with low cost. By discovering the diverse potential of biomedicine, we can provide better healthcare in the world. © 2020 Elsevier Inc. All rights reserved. en_US
dc.identifier.doi 10.1016/B978-0-12-819541-3.00022-0
dc.identifier.isbn 978-012819541-3
dc.identifier.scopus 2-s2.0-85147597451
dc.identifier.uri https://doi.org/10.1016/B978-0-12-819541-3.00022-0
dc.identifier.uri https://hdl.handle.net/11147/14768
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.relation.ispartof Biodiversity and Biomedicine: Our Future en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Biomedicine en_US
dc.subject Cancer en_US
dc.subject Drug discovery en_US
dc.subject Personalized therapy en_US
dc.title Personalized Biomedicine in Cancer: From Traditional Therapy To Sustainable Healthcare en_US
dc.type Book Part en_US
dspace.entity.type Publication
gdc.author.scopusid 57215384419
gdc.author.scopusid 56422406900
gdc.author.scopusid 9636164400
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C5
gdc.coar.access metadata only access
gdc.coar.type text::book::book part
gdc.collaboration.industrial false
gdc.description.department Izmir Institute of Technology en_US
gdc.description.departmenttemp Ulu G.T., İzmir Institute of Technology, Faculty of Science, Department of Molecular Biology and Genetics, İzmir, Turkey; Kiraz Y., İzmir Institute of Technology, Faculty of Science, Department of Molecular Biology and Genetics, İzmir, Turkey; Baran Y., İzmir Institute of Technology, Faculty of Science, Department of Molecular Biology and Genetics, İzmir, Turkey en_US
gdc.description.endpage 457 en_US
gdc.description.publicationcategory Kitap Bölümü - Uluslararası en_US
gdc.description.scopusquality N/A
gdc.description.startpage 441 en_US
gdc.description.wosquality N/A
gdc.identifier.openalex W3044185362
gdc.index.type Scopus
gdc.oaire.diamondjournal false
gdc.oaire.impulse 1.0
gdc.oaire.influence 2.6699352E-9
gdc.oaire.isgreen false
gdc.oaire.popularity 2.6139557E-9
gdc.oaire.publicfunded false
gdc.openalex.collaboration National
gdc.openalex.fwci 1.17648855
gdc.openalex.normalizedpercentile 0.8
gdc.opencitations.count 1
gdc.plumx.crossrefcites 1
gdc.plumx.mendeley 23
gdc.plumx.scopuscites 3
gdc.scopus.citedcount 3
relation.isAuthorOfPublication.latestForDiscovery 679729f2-b268-4d85-b686-4c8a63dae23f
relation.isOrgUnitOfPublication.latestForDiscovery 9af2b05f-28ac-4003-8abe-a4dfe192da5e

Files